Skip to main content

Table 4 Comparison of anthropometric, clinical and densitometric variables between patients with AS with and without sarcopenia according to EWGSOP definition

From: Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis?

  AS patients with sarcopenia N = 23 AS patients without sarcopenia N = 44 P
Age (yrs): m (SD) 42.3 (11.6) 40.1 (10.7) NS
Height (m): m (SD) 1.71 (0.06) 1.73 (0.06) NS
Weight (kg): m (SD) 64.6 (11.0) 77.9 (11.9) <0.0001
BMI (kg/m2): m (SD) 21.6 (3.6) 25.7 (3.7) <0.0001
Disease duration (yrs): m (SD) 11.6 (9.1) 8.6 (6.6) NS
Lumbar spine BMD (g/cm2): m (SD) 1.092 (0.23) 1.134 (0.14) NS
Lumbar spine T-score: m (SD) −0.97 (3.4) −0.47 (1.2) 0.032
Total hip BMD (g/cm2): m (SD) 0.914 (0.13) 1.006 (0.23) 0.017
Total hipT-score: m (SD) −0.96 (1.4) −0.35 (1.1) 0.017
Osteoporosis: n (%) 7 (30.4) 4 (9.1) 0.038
BASDAI (0–10): m (SD) 4.4 (2.4) 3.4 (2.5) 0.002
BASMI (0–10): m (SD) 2.9 (2.2) 2.7 (2.7) NS
BASFI (0–100): m (SD) 44.5 (26.5) 38.0 (25.5) NS
BAS-G (0–100): m (SD) 19.7 (16.8) 16.1 (22.6) NS
Hand grip strength (kg): m (SD) 19.5 (7.0) 25.3 (9.8) NS
Timed get-up-and-go test (sec) < 10 sec: n (%) 14 (66.7) 33 (75.0) NS
Arm circumference (cm): m (SD) 26.8 (1.9) 30.5 (3.9) 0.002
Waist circumference (cm): m (SD) 85.7 (10.8) 94.1 (11.4) <0.0001
MNA test (0–17): m (SD) 0.34 (0.4) 0.19 (0.3) NS
SASSS (0–72): m (SD) 14.3 (18.7) 9.5 (14.6) NS
CRP (mg/l): m (SD) 21.8 (10.1) 11.6 (10.1) NS
ESR (mm/H): m (SD) 31.0 (22.3) 24.2 (18.4) NS
Patients taking TNFi: n (%) 11 (33.3) 11 (32.4) NS
  1. BMI body mass index, CRP C-reactive protein, ESR erythrocyte sedimentation rate, MNA Mini Nutritional Assessment, SASSS Stoke Ankylosing Spondylitis Spinal Score